We have recently been focusing on the growth in the use of biomarkers in clinical trials, and today pulled data from BiomarkerBase to examine the growth in the number of unique biomarkers that are being used in the inclusion/exclusion criteria of active clinical...
Last week our chart of the week was a look at the total number of clinical trials started annually that include biomarkers, with a projection out to 2020. The hockey stick shape of the growth rate was striking, so much so that we decided to follow-up and ask...
Diagnostic tests with algorithms seem to slow review periods on average. Share this Image On Your Site <p><strong>Please include attribution to https://amplion.wpengine.com/biomarker-trends with this graphic.</strong><br /><br /><a...
We’ve covered the LDT regulation evolution for some time now. To give some perspective we’ve created the following infographic showing the history of LDT regulation. To use it in your own content check out the code snippet below the infographic. We only...
The most experienced test developers get their tests through the process of FDA approval or clearance 70 days faster on average and 90 days faster on median. The first quartile (bottom of box) Third quartile (top of box) The median (horizontal line within box) The...